论文部分内容阅读
目的:观察阿奇霉素治疗支原体肺炎的临床疗效。方法:选取我院收治的支原体肺炎患者82例,随机分为观察组和对照组各41例,观察组在常规治疗基础上使用阿奇霉素治疗,对照组使用红霉素治疗,观察两组患者临床疗效和不良反应并进行比较。结果:观察组临床治疗总有效率明显高于对照组(X2=4.78,P<0.05),观察组不良反应发生率明显低于对照组(X2=7.75,P<0.05)。结论:阿奇霉素治疗支原体肺炎临床疗较好,且不良反应较少、安全性较高,值得在临床上推广使用。
Objective: To observe the clinical efficacy of azithromycin in the treatment of mycoplasma pneumonia. Methods: 82 cases of Mycoplasma pneumonia admitted in our hospital were randomly divided into observation group and control group, 41 cases in each group. The observation group was treated with azithromycin on the basis of conventional treatment and the control group was treated with erythromycin. The clinical efficacy And adverse reactions and compared. Results: The total effective rate of clinical observation in observation group was significantly higher than that in control group (X2 = 4.78, P <0.05). The incidence of adverse reactions in observation group was significantly lower than that in control group (X2 = 7.75, P <0.05). Conclusion: Azithromycin in the treatment of mycoplasma pneumonia clinical treatment is good, and less adverse reactions, high safety, it is worth promoting in clinical use.